Clinical Trials Logo

Filter by:
NCT ID: NCT00662779 Withdrawn - Clinical trials for Exercise-induced Bronchospasm

Bronchoprotective Effect of Arformoterol in Children With Exercise-Induced Bronchospasm (EIB)

EIB
Start date: April 2008
Phase: Phase 3
Study type: Interventional

It is our primary hypothesis that pretreatment with arformoterol will provide superior protection against EIB in children with mild-moderate asthma compared to placebo added to the current asthma regimen. Our secondary hypothesis is that nebulized arformoterol has comparable protection against EIB compared to inhaled formoterol by dry powder inhaler.

NCT ID: NCT00666081 Withdrawn - Cancer Clinical Trials

Study to Investigate AKT Inhibitor GSK690693 in Subjects With Relapsed or Refractory Hematologic Malignancies

Start date: April 2008
Phase: Phase 1
Study type: Interventional

This is a two-part study in subjects with hematologic malignancies designed to find the maximum tolerated dose (MTD) of GSK690693 (Part 1). Part 2 is designed to determine the efficacy of GSK690693 in a subset of subjects with hematologic malignancies.

NCT ID: NCT00668499 Withdrawn - Mesothelioma Clinical Trials

A Study of VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant Mesothelioma

Start date: April 2008
Phase: Phase 1/Phase 2
Study type: Interventional

This will be a single institution non-randomized phase I/II trial for patients with malignant mesothelioma stage II and above, who have not received prior chemotherapy for their disease. The purpose of this phase is to select a dose of VEGF-AS (antiangiogenesis drug)to be given with standard doses of pemetrexed followed by cisplatin on day 1 of a 21-day cycle.

NCT ID: NCT00668681 Withdrawn - Clinical trials for AAA Graft Repair to Extend Life of Implant

Evaluation of EndoRefix Endovascular Delivery System and Staple

EndoRefix
Start date: April 2008
Phase: N/A
Study type: Interventional

This study is intended to provide data to verify safe delivery of a staple previously intended for use in open surgical procedures. A newly modified delivery system will provide endovascular access for implantation of a staple during endovascular graft procedures.

NCT ID: NCT00670696 Withdrawn - Healthy Clinical Trials

A Study to Compare the Efficacy of Rapydan Versus Tetracaine Gel

Start date: April 2008
Phase: Phase 4
Study type: Interventional

Tetracaine gel 4% is a topical anaesthetic gel commonly used in the UK that contains 40 mg of tetracaine base per gram. Adequate anaesthesia can usually be achieved following a 30 minute application time for venopuncture and a 45 minute application time for venous cannulation. The hypothesis is that Rapydan medicated plaster is more effective than tetracaine gel in preventing venous cannulation related pain when applied for the recommended treatment durations of 30 minutes and 45 minutes respectively.

NCT ID: NCT00671463 Withdrawn - Pancreatic Cancer Clinical Trials

Pancreatic Stent to Prevent Leak After Distal Pancreatectomy

LEAPS
Start date: April 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate an intervention to prevent complications after pancreas surgery. The goal is to determine if placing a stent into the pancreatic duct before surgery will decrease or prevent leaking from the pancreatic duct after surgery. Leaks are common after pancreas surgery and can result in serious problems and post-operative pain. The study will compare two groups. One group will have the stent before surgery, and the other group will have standard pancreas surgery, no endoscopy, and no stent.

NCT ID: NCT00672464 Withdrawn - Schizophrenia Clinical Trials

Cardio Risk of Acute Schizophrenia Olanzapine Duke

CRASOD
Start date: April 2008
Phase: Phase 4
Study type: Interventional

Primary Objective: To compare added metformin and/or added simvastatin versus no intervention in reducing or eliminating increased cardiovascular risk (as estimated by elevation in non-HDL cholesterol levels) during the treatment of schizophrenia with olanzapine. Secondary Objective(s): To compare added metformin and/or added simvastatin versus no intervention in reducing or eliminating increased cardiovascular risk (as estimated by elevation in triglyceride levels) during the treatment of schizophrenia with olanzapine. To compare added metformin and/or added simvastatin versus no intervention in reducing or eliminating increased cardiovascular risk (as estimated by C-reactive protein levels) during the treatment of schizophrenia with olanzapine

NCT ID: NCT00673972 Withdrawn - Clinical trials for Functional Dyspepsia

Comparative Study of Epigastric Pain Syndrome and Postprandial Distress Syndrome

Start date: April 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare postprandial distress syndrome and epigastric pain syndrome in demographics psychological features, infection of Helicobacter pylori, gastric emptying and therapeutic response to lansoprazole.

NCT ID: NCT00676000 Withdrawn - Pain Clinical Trials

Randomized Trial of Interrupted Versus Continuous Vaginal Closure of Anterior Repair With Mesh

Start date: April 2008
Phase: N/A
Study type: Interventional

Vaginal prolapse is a common condition that is treated with surgical correction. Recently surgeons have been using mesh to augment the repair of vaginal prolapse. Common complications of this surgery include vaginal pain, pain during sex, infection or erosion of the mesh in the vagina. There are different ways to close the vaginal wall over the mesh used in these procedures. Currently, there is no accepted standard method of closing the vaginal wall. The purpose of this study is to find out the best way to close the surgical wound in the vagina. We will compare interrupted closure (separate stitches) to continuous closure (one long, running stitch). We hope to show in our study that one method of closure is better than the other.

NCT ID: NCT00676559 Withdrawn - Clinical trials for Diabetic Macular Edema

Combined aPproach to Treatment Using Ranibizumab and Efalizumab for Diabetic Macular Edema Study: The CAPTURE DME Study

CAPTURE
Start date: April 2008
Phase: Phase 1
Study type: Interventional

This study looks to continue the study of anti-vegf therapy in patients with macular edema, and compare it to an anti-inflammatory therapy and a combined Anti-vegf and anti-inflammatory.